21035-26-7 Usage
General Description
1-(1H-benzimidazol-2-yl)-3-ethylurea, also known as mepenzolate, is a chemical compound that belongs to the class of benzimidazole derivatives. It is a synthetic anticholinergic agent that acts as a muscarinic receptor antagonist. Mepenzolate is commonly used as a medication to treat gastrointestinal conditions such as peptic ulcers, irritable bowel syndrome, and gastritis. It works by blocking the action of acetylcholine on smooth muscle cells in the digestive system, which helps to reduce symptoms such as abdominal pain, cramps, and spasms. Mepenzolate is available in oral tablet form and is typically taken multiple times a day as directed by a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 21035-26-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,0,3 and 5 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 21035-26:
(7*2)+(6*1)+(5*0)+(4*3)+(3*5)+(2*2)+(1*6)=57
57 % 10 = 7
So 21035-26-7 is a valid CAS Registry Number.
21035-26-7Relevant articles and documents
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents
Basarab, Gregory S.,Manchester, John I.,Bist, Shanta,Boriack-Sjodin, P. Ann,Dangel, Brian,Illingworth, Ruth,Sherer, Brian A.,Sriram, Shubha,Uria-Nickelsen, Maria,Eakin, Ann E.
, p. 8712 - 8735 (2013/12/04)
The discovery and optimization of a new class of bacterial topoisomerase (DNA gyrase and topoisomerase IV) inhibitors binding in the ATP domain are described. A fragment molecule, 1-ethyl-3-(2-pyridyl)urea, provided sufficiently potent enzyme inhibition (
